169 related articles for article (PubMed ID: 19283771)
1. Oxidative demethylenation and subsequent glucuronidation are the major metabolic pathways of berberine in rats.
Liu Y; Hao H; Xie H; Lv H; Liu C; Wang G
J Pharm Sci; 2009 Nov; 98(11):4391-401. PubMed ID: 19283771
[TBL] [Abstract][Full Text] [Related]
2. Regioselective glucuronidation of tanshinone iia after quinone reduction: identification of human UDP-glucuronosyltransferases, species differences, and interaction potential.
Wang Q; Hao H; Zhu X; Yu G; Lai L; Liu Y; Wang Y; Jiang S; Wang G
Drug Metab Dispos; 2010 Jul; 38(7):1132-40. PubMed ID: 20382756
[TBL] [Abstract][Full Text] [Related]
3. Hepatic glucuronidation of isoneochamaejasmin a from the traditional Chinese medicine Stellera chamaejasme L. Root.
Yu L; Pu J; Zuo M; Zhang X; Cao Y; Chen S; Lou Y; Zhou Q; Hu H; Jiang H; Chen J; Zeng S
Drug Metab Dispos; 2014 Apr; 42(4):735-43. PubMed ID: 24452863
[TBL] [Abstract][Full Text] [Related]
4. Detoxication versus Bioactivation Pathways of Lapatinib In Vitro: UGT1A1 Catalyzes the Hepatic Glucuronidation of Debenzylated Lapatinib.
Nardone-White DT; Bissada JE; Abouda AA; Jackson KD
Drug Metab Dispos; 2021 Mar; 49(3):233-244. PubMed ID: 33376146
[No Abstract] [Full Text] [Related]
5. CYP450 1A2 and multiple UGT1A isoforms are responsible for jatrorrhizine metabolism in human liver microsomes.
Zhou H; Shi R; Ma B; Ma Y; Wang C; Wu D; Wang X; Cheng N
Biopharm Drug Dispos; 2013 Apr; 34(3):176-85. PubMed ID: 23299247
[TBL] [Abstract][Full Text] [Related]
6. Species difference in glucuronidation formation kinetics with a selective mTOR inhibitor.
Berry LM; Liu J; Colletti A; Krolikowski P; Zhao Z; Teffera Y
Drug Metab Dispos; 2014 Apr; 42(4):707-17. PubMed ID: 24423753
[TBL] [Abstract][Full Text] [Related]
7. Role of cytochrome P450 and UDP-glucuronosyltransferases in metabolic pathway of homoegonol in human liver microsomes.
Kwon SS; Kim JH; Jeong HU; Ahn KS; Oh SR; Lee HS
Drug Metab Pharmacokinet; 2015 Aug; 30(4):305-13. PubMed ID: 26163112
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and metabolism of jatrorrhizine, a gastric prokinetic drug candidate.
Shi R; Zhou H; Ma B; Ma Y; Wu D; Wang X; Luo H; Cheng N
Biopharm Drug Dispos; 2012 Apr; 33(3):135-45. PubMed ID: 22344858
[TBL] [Abstract][Full Text] [Related]
9. Acyl glucuronidation of fluoroquinolone antibiotics by the UDP-glucuronosyltransferase 1A subfamily in human liver microsomes.
Tachibana M; Tanaka M; Masubuchi Y; Horie T
Drug Metab Dispos; 2005 Jun; 33(6):803-11. PubMed ID: 15769885
[TBL] [Abstract][Full Text] [Related]
10. In vitro glucuronidation of Armillarisin A: UDP-glucuronosyltransferase 1A9 acts as a major contributor and significant species differences.
Sun D; Zhu L; Xiao L; Xia Y; Ge G; Cao Y; Wu Y; Yin J; Yang L
Xenobiotica; 2014 Nov; 44(11):988-95. PubMed ID: 24916899
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of the anthelmintic drug niclosamide by cytochrome P450 enzymes and UDP-glucuronosyltransferases: metabolite elucidation and main contributions from CYP1A2 and UGT1A1.
Lu D; Ma Z; Zhang T; Zhang X; Wu B
Xenobiotica; 2016; 46(1):1-13. PubMed ID: 26068521
[TBL] [Abstract][Full Text] [Related]
12. UGT-mediated metabolism plays a dominant role in the pharmacokinetic behavior and the disposition of morusin in vivo and in vitro.
Hou C; Liu W; Liang Z; Han W; Li J; Ye L; Liu M; Cai Z; Zhao J; Chen Y; Liu S; Tang L
J Pharm Biomed Anal; 2018 May; 154():339-353. PubMed ID: 29571132
[TBL] [Abstract][Full Text] [Related]
13. Glucuronidation of zearalenone, zeranol and four metabolites in vitro: formation of glucuronides by various microsomes and human UDP-glucuronosyltransferase isoforms.
Pfeiffer E; Hildebrand A; Mikula H; Metzler M
Mol Nutr Food Res; 2010 Oct; 54(10):1468-76. PubMed ID: 20397195
[TBL] [Abstract][Full Text] [Related]
14. Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes.
Li Y; Ren G; Wang YX; Kong WJ; Yang P; Wang YM; Li YH; Yi H; Li ZR; Song DQ; Jiang JD
J Transl Med; 2011 May; 9():62. PubMed ID: 21569619
[TBL] [Abstract][Full Text] [Related]
15. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
[TBL] [Abstract][Full Text] [Related]
16. Sequential metabolism of sesamin by cytochrome P450 and UDP-glucuronosyltransferase in human liver.
Yasuda K; Ikushiro S; Kamakura M; Munetsuna E; Ohta M; Sakaki T
Drug Metab Dispos; 2011 Sep; 39(9):1538-45. PubMed ID: 21622626
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel N-carbamoyl glucuronide: in vitro, in vivo, and mechanistic studies.
Gunduz M; Argikar UA; Baeschlin D; Ferreira S; Hosagrahara V; Harriman S
Drug Metab Dispos; 2010 Mar; 38(3):361-7. PubMed ID: 20008038
[TBL] [Abstract][Full Text] [Related]
18. In vitro metabolism of l-corydalmine, a potent analgesic drug, in human, cynomolgus monkey, beagle dog, rat and mouse liver microsomes.
Tang X; Di X; Zhong Z; Xie Q; Chen Y; Wang F; Ling Z; Xu P; Zhao K; Wang Z; Liu L; Liu X
J Pharm Biomed Anal; 2016 Sep; 128():98-105. PubMed ID: 27239758
[TBL] [Abstract][Full Text] [Related]
19. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
Kaji H; Kume T
Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
[TBL] [Abstract][Full Text] [Related]
20. Characterization of 2-[[4-[[2-(1H-tetrazol-5-ylmethyl)phenyl]methoxy]methyl]quinoline N-glucuronidation by in vitro and in vivo approaches.
Stevens JC; Fayer JL; Cassidy KC
Drug Metab Dispos; 2001 Mar; 29(3):289-95. PubMed ID: 11181497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
